Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Current Deferred Revenue (2023 - 2025)

Cannabis Bioscience International Holdings' Current Deferred Revenue history spans 2 years, with the latest figure at $12000.0 for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $12000.0 in Q3 2025 year-over-year; TTM through Aug 2025 was $12000.0, a N/A change, with the full-year FY2023 number at $28641.0, changed N/A from a year prior.
  • Current Deferred Revenue hit $12000.0 in Q3 2025 for Cannabis Bioscience International Holdings, down from $28641.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CBIH hit a ceiling of $28641.0 in Q2 2023 and a floor of $12000.0 in Q3 2025.